|
Industry Urged to Involve Patients Early, Solicit Input on PROs
Device and drugmakers need to engage patients earlier in the development process to ensure they are addressing symptoms and measuring outcomes that matter to patients, patient advocates say.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives